TREATMENT SET TS346618 injection, solution
TREATMENT SET TS346619 injection, solution
TREATMENT SET TS346620 injection, soluti United States - English - NLM (National Library of Medicine)

treatment set ts346618 injection, solution treatment set ts346619 injection, solution treatment set ts346620 injection, soluti

antigen laboratories, inc. - betula populifolia pollen (unii: 23h70fyj5u) (betula populifolia pollen - unii:23h70fyj5u), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), plantago lanceolata pollen (unii: do87t1u2ci) (plantago lanceolata pollen - unii:do87t1u2ci), urtica dioica pollen (unii: dnb59m1nvu) (urtica dioica pollen - unii:dnb59m1nvu), amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), periplaneta americana (unii: 2rq1l9n0 - betula populifolia pollen 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS349930 injection, solution
TREATMENT SET TS349931 injection, solution
TREATMENT SET TS349945- treatment set ts United States - English - NLM (National Library of Medicine)

treatment set ts349930 injection, solution treatment set ts349931 injection, solution treatment set ts349945- treatment set ts

antigen laboratories, inc. - plantago lanceolata pollen (unii: do87t1u2ci) (plantago lanceolata pollen - unii:do87t1u2ci), chenopodium album pollen (unii: 098lkx5ncn) (chenopodium album pollen - unii:098lkx5ncn), urtica dioica pollen (unii: dnb59m1nvu) (urtica dioica pollen - unii:dnb59m1nvu), amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), cynodon dactylon pollen (unii: 175f461w - plantago lanceolata pollen 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS334972 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts334972 injection, solution

antigen laboratories, inc. - amaranthus retroflexus pollen (unii: 73b14px5fw) (amaranthus retroflexus pollen - unii:73b14px5fw), salsola kali pollen (unii: 2mh135kc6g) (salsola kali pollen - unii:2mh135kc6g), plantago lanceolata pollen (unii: do87t1u2ci) (plantago lanceolata pollen - unii:do87t1u2ci), carya illinoinensis pollen (unii: pyo4jr720y) (carya illinoinensis pollen - unii:pyo4jr720y), carya alba pollen (unii: g2a764t54b) (carya alba pollen - unii:g2a764t54b), juniperus virginiana pollen (unii: py0ja16r2g) (juniperus virg - amaranthus retroflexus pollen 0.0000133 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

4FARMERS I-PYR 750 WG HERBICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4farmers i-pyr 750 wg herbicide

4 farmers australia pty ltd - imazapyr - granular formulation - imazapyr imidazolinone active 750.0 g/kg - herbicide - agricultural/farm buildings | commercial area - general | industrial land or area | non-crop area - general | public service are - annual or wimmera ryegrass | barnyard grass or water grass | blackberry nightshade | blady grass | bokhara clover | bracken | canadian fleabane | capeweed | couch grass | deadnettle | dock | feathertop rhodes grass | johnson grass | liverseed grass - seed | london rocket | mayne's pest | medic | melilotus or hexham scent | mintweed | panic | paspalum | paterson's curse | plains grass | prairie or annual prairie grass | prickly lettuce | purple top | queensland bluegrass | rubber vine | scented top | scrub nettle | sedge | slender celery | soft roly poly | sow or milk thistle | st barnaby's thistle | summer or crab grass | thornapple | thunbergia | turnip weed | variegated thistle | vasey grass | warrego grass | wild oat | wild or mediterranean turnip | wireweed or knotweed - seed | annual medic | annual summer grass | austral bracken | black nightshade | blessed thistle | blue salvia | blue thunbergia | blue top | blue trumpet vine | bristly speargrass | broadleaf dock | bromus catharticus | bromus stamineus

WESTERN WATER HEMP- Western Water Hemp United States - English - NLM (National Library of Medicine)

western water hemp- western water hemp

antigen laboratories, inc. - amaranthus tuberculatus pollen (unii: 92n6w6ko2g) (amaranthus tuberculatus pollen - unii:92n6w6ko2g) - amaranthus tuberculatus pollen 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

Allergenic Extract United States - English - NLM (National Library of Medicine)

allergenic extract

antigen laboratories, inc. - salix lucida ssp. lasiandra pollen (unii: 9p9t267qmr) (salix lucida ssp. lasiandra pollen - unii:9p9t267qmr) - salix lucida ssp. lasiandra pollen 0.05 g in 1 ml - allergenic extract is used for diagnostic testing and for the treatment (immunotherapy) of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. confirmation is determined by skin testing. diagnostic use of allergenic extracts usually begins with direct skin testing. this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. do not administer in the presence of diseases characterized by bleeding diathesis. individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying disease, possibly due to routine immunization. patients who have experienced a recent myocardial infarction may not be tolerant of immunotherapy. children with nephrotic syndrome probably should not receive injections due to immunization causing exacerbation of nephrotic disease.

TREATMENT SET TS335657 injection, solution
TREATMENT SET TS335683 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts335657 injection, solution treatment set ts335683 injection, solution

antigen laboratories, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), canis lupus familiaris hair (unii: 05s7l91ztr) (canis lupus familiaris hair - unii:05s7l91ztr), periplaneta americana (unii: 2rq1l9n089) (periplaneta americana - unii:2rq1l9n089), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), juniperus virginiana pollen (unii: py0ja16r2g) - dermatophagoides farinae 400 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS340796 injection, solution
TREATMENT SET TS340826 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts340796 injection, solution treatment set ts340826 injection, solution

antigen laboratories, inc. - dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), periplaneta americana (unii: 2rq1l9n089) (periplaneta americana - unii:2rq1l9n089), juglans nigra pollen (unii: 1bv28146zr) (juglans nigra pollen - unii:1bv28146zr), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense p - dermatophagoides farinae 400 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS342922 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts342922 injection, solution

antigen laboratories, inc. - dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), dermatophagoides farinae (unii: pr9u2ypf3q) (dermatophagoides farinae - unii:pr9u2ypf3q), cynodon dactylon pollen (unii: 175f461w10) (cynodon dactylon pollen - unii:175f461w10), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), acer negundo pollen (unii: p6k070ar8v) (acer negundo pollen - unii:p6k070ar8v), felis catus hair (unii: 1564hd0n96) (felis c - dermatophagoides pteronyssinus 16 [au] in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski

TREATMENT SET TS336437 injection, solution United States - English - NLM (National Library of Medicine)

treatment set ts336437 injection, solution

antigen laboratories, inc. - alternaria alternata (unii: 52b29rec7h) (alternaria alternata - unii:52b29rec7h), ambrosia trifida pollen (unii: ku1v1898xx) (ambrosia trifida pollen - unii:ku1v1898xx), ambrosia artemisiifolia pollen (unii: k20y81aco3) (ambrosia artemisiifolia pollen - unii:k20y81aco3), ambrosia psilostachya pollen (unii: rx18m46k8l) (ambrosia psilostachya pollen - unii:rx18m46k8l), dermatophagoides pteronyssinus (unii: 57l1z5378k) (dermatophagoides pteronyssinus - unii:57l1z5378k), carya alba pollen (unii: g2a764t54b - alternaria alternata 0.002 g in 1 ml - when the natural exposure to elevated aeroallergens produces symptoms as described under clinical pharmacology, specific diagnosis and therapeutic procedures are indicated. clearly, important clues to the cause of a person's allergic condition can be gleaned from a thorough history and careful physical examination. diagnostic tests - in vitro or in vivo - serve only to confirm the physician's suspicions or to improve investigative skills. specific diagnosis is especially indicated when the patient's symptoms are not controlled by medication. when immunotherapy is contemplated demonstration of sensitivity to a specific allergenic extract is necessary. an orderly approach to the use of diagnostic tests usually begins with direct skin testing. 5,6,11 this product is not intended for treatment of patients who do not manifest immediate hypersensitivity reactions to the allergenic extract following skin testing. there are no absolute contraindications; however, extreme caution is necessary when using diagnostic ski